Line 35: | Line 35: | ||
<li><a href="https://2016.igem.org/Team:Paris_Saclay/CRISPR-Cas9">CRISPR/Cas9</a></li> | <li><a href="https://2016.igem.org/Team:Paris_Saclay/CRISPR-Cas9">CRISPR/Cas9</a></li> | ||
<li><a href="https://2016.igem.org/Team:Paris_Saclay/Strategy">Strategy</a></li> | <li><a href="https://2016.igem.org/Team:Paris_Saclay/Strategy">Strategy</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:Paris_Saclay/Expriments">Experiments</a></li> | ||
<li><a href="https://2016.igem.org/Team:Paris_Saclay/Notebook">Notebook</a></li> | <li><a href="https://2016.igem.org/Team:Paris_Saclay/Notebook">Notebook</a></li> | ||
<li><a href="https://2016.igem.org/Team:Paris_Saclay/Description">Results</a></li> | <li><a href="https://2016.igem.org/Team:Paris_Saclay/Description">Results</a></li> |
Revision as of 12:20, 15 October 2016